Precede Biosciences’ liquid biopsy platform yields insight into the genes and pathways in diseased tissue. Based on Dana-Farber Cancer Institute research, the startup aims to support biopharma drug R&D as it also develops the technology for clinical care applications.
Brigham and Women’s hospital has also launched a digital innovation hub called iHub that works with clinicians, researchers, and staff to accelerate and commercialize digital health ideas.
On day two of MedCity CONVERGE, John Quackenbush of the Dana-Farber Cancer Institute highlighted the benefits and the challenges that accompany big data.
The brick-and-mortar retail industry isn't doing well. As shopping malls clear out, landlords are finding medical providers eager to take over the empty mall space.
The goal is to see if the extra motivation from fitness trackers, Wi-Fi scales and health coaches can help the patients lose weight and, ultimately, prevent a return of the disease.
“Our ability to sequence genes has gotten ahead of our ability to know what it means,” said Eric P. Winer, the director of the breast oncology program at Harvard’s Dana-Farber Cancer Institute.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The startup created from Dana-Farber Cancer Institute announced today the closing of a $73 million Series A round of financing and a promising partnership with Roche.
Women have been largely in charge of making sure unwanted pregnancies don’t happen unexpectedly due to the availability of various forms of contraception. While men have the obvious choice of using condoms or in extreme cases going for the snip (and there have been talks of a future pill-form for men), other potentially affective options […]
ESPN anchor Stuart Scott died Sunday morning at the age of 49 after an eight-year battle with cancer. He was, in many ways, bigger than ESPN itself: he was one of the network’s most popular personalities, and his unique booyah catchphrases inspired a generation of broadcasters. So it’s no surprise that his approach to […]
Gene regulation startup Syros Pharmaceuticals has raised a $53.1 million from 16 investors, according to regulatory filings. This financing round was led by “a large, Boston-based public investment firm,” also includes new investors Polaris Partners, Aisling Capital and Redmile Group. The current investors – Flagship Ventures, ARCH Venture Partners, WuXi PharmaTech Corporate Ventuer Fund and […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In the same way that funding for early-stage innovations is changing, so is how those innovations are translated from the bench to the bedside. “Our office, which was formerly a traditional tech transfer office, has very much become a business office,” said Gary Sclar from the Dana-Farber Cancer Institute’s Office of Research and Technology Ventures. […]
